Kit for detecting bone resorption, application of kit and preparation method of bone resorption detection material

By contacting osteoclasts with the use of eggshells, the accuracy and operational complexity of existing bone resorption detection products are solved, and multi-dimensional analysis of bone resorption function and cell morphology is achieved, which is suitable for different patient groups. The detection reduces cost and operational complexity.

CN119082249APending Publication Date: 2024-12-06THE THIRD AFFILIATED HOSPITAL OF SOUTHERN MEDICAL UNIV (ACAD OF ORTHOPEDICS GUANGDONG PROVINCE)
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411190422.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-28
Publication Date
2024-12-06

AI Technical Summary

Technical Problem

The existing bone resorption detection products have problems such as inaccurate detection, complex operation, high cost, and inapplicable to minors and fractured patients, and cannot effectively observe the resorption status of osteoclasts and the expression and localization of organelles.

Method used

Using multi-well plates prepared from eggshells as bone resorption detection material, the absorption pits are detected by contacting osteoclasts and observing cell morphology, providing more realistic bone resorption detection data, and multi-dimensional analysis is performed through immunohistochemistry and chemical dye staining. .

Benefits of technology

The quantification of bone resorption function and observation of cell morphology are achieved, and more accurate bone resorption research data is provided, which is suitable for bone resorption detection in different patient groups, reducing the detection cost and operational complexity.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119082249A_ABST
    Figure CN119082249A_ABST
Patent Text Reader

Abstract

The invention discloses a kit for detecting bone resorption, application of the kit and a preparation method of a bone resorption detection material, and relates to the technical field of bone resorption detection. The kit comprises a porous plate and a bone resorption detection material prepared from eggshells. The kit not only can be used for observing the bone resorption function and quantification, but also can be used for observing the form number and size of cells in a bone resorption state, and provides a more real research state of bone resorption cells. The kit provided by the invention can realize multi-dimensional observation of the absorption pit. In addition, the kit provided by the invention has a good application prospect in osteoclast bone resorption detection or bone resorption drug screening.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of bone absorption detection, in particular to a kit for detecting bone absorption and its application and a method for preparing a bone absorption detection material. Background Art

[0002] The balance between bone absorption and bone formation is an important basis for maintaining normal bone function and metabolism. Many current bone diseases are caused by abnormal bone absorption, including osteoporosis, bone tumors, osteosclerosis, etc. Therefore, in the field of basic research, there is an urgent need for a product that can effectively detect bone absorption function and provide reliable and comprehensive detection data for further research on bone absorption.

[0003] At present, through the study of the bone resorption function of osteoclasts, bisphosphonates that affect osteoclast formation have been discovered. They are mainly used in clinical osteoporosis patients. However, this drug has certain limitations in its use for minors and osteoporosis patients with fractures. Osteoclasts are the key factor in bone transformation. Bisphosphonates can effectively inhibit the formation of osteoclasts, and also inhibit bone transformation, leading to the inhibition of bone development in minors, and also inhibiting bone repair in patients with fractures. In order to study and develop more bone resorption drugs suitable for different patients and deeply explore the abnormal bone resorption mechanism of different diseases, better bone resorption examination methods and more complete data are needed.

[0004] Bone resorption is the main function of osteoclasts. In vivo, osteoclasts adhere to the bone matrix, form a closed and independent microenvironment with the bone surface through their own resorption ring, and release H + , so that the absorption ring forms a local acidic microenvironment, the acidic environment dissolves the local bone matrix, and forms absorption pits. Absorption pits are the most direct effect of osteoclast bone absorption function, and their number, size, and depth reflect the strength of bone absorption capacity.

[0005] There are two types of products available on the market for detecting bone absorption. The first type is bone slices, which are mainly from cow bones. However, they are complicated to process, have harsh production conditions, and are expensive. They are no longer used or produced because they carry certain pathogenic microorganisms that affect the experiment if they are not thoroughly disinfected. The second type is bone absorption material coated on the bottom of the well plate. This is mainly done by laying a layer of hydroxyapatite (the main inorganic component of bone) material on the bottom of the well plate, culturing osteoclasts, then removing the osteoclasts, and observing the area of ​​absorbed material under a microscope. This test plate has certain limitations: first, the material of the well plate is relatively thin, and its tightness is too different from that of the bone; second, during the experimental operation, the pipette tip is easy to poke the material, or the pipetting pressure is too high, and the liquid ejected from the pipette tip is easy to wash away the material, causing certain human errors; third, the solubility of the material itself and its effect on some treatment drugs cannot be estimated; fourth, the product uses a well plate of specific specifications to lay the material, and the same plate needs to be used repeatedly, which is easy to contaminate and inconvenient to sterilize; fifth, it is impossible to evaluate osteoclasts with strong absorption function. In the past, it was evaluated by the depth of bone absorption pits, and the absorption plate does not have data on the depth of absorption pits. A bone absorption test currently on sale in the market costs 3,582 yuan for a 48-well plate. Currently, there are only two specifications of 48-well plate and 96-well plate, and the consumption of osteoclast induction reagents and treatment drugs is extremely large.

[0006] In addition, the current research on osteoclast organelles and protein levels is all in a non-absorption state, and the materials cannot be used to observe organelles or detect protein expression and location in the state of osteoclast resorption. The current bone slices are too dense to be prepared as thin slices, and have poor light transmittance and cannot be observed under a microscope. The bone resorption plate material is too thin and loose, easy to absorb, and cannot maintain the state of osteoclast resorption. Therefore, in order to better study the bone resorption regulation mechanism of osteoclasts, it is urgent to find new bone resorption materials that can observe the morphology of osteoclasts in the state of bone resorption, the expression and location of organelles and proteins.

[0007] In view of this, the present invention is proposed. Summary of the invention

[0008] The purpose of the present invention is to provide a kit for detecting bone absorption and its application and a method for preparing a bone absorption detection material to solve the above technical problems.

[0009] The present invention is achieved in that:

[0010] In a first aspect, the present invention provides a kit for bone absorption detection, comprising: a multi-well plate and a bone absorption detection material prepared from eggshells.

[0011] In a second aspect, the present invention provides an application of a kit for detecting osteoclast bone resorption or screening bone resorption drugs, wherein the application includes any of the following application modes:

[0012] (1) contacting the microplate of the kit with osteoclasts to detect absorption pits;

[0013] (2) contacting the microplate of the kit with osteoclasts to obtain cell images;

[0014] (3) The microplate of the kit is placed in contact with osteoclasts, and after obtaining a cell image, absorption pits are detected.

[0015] In a third aspect, the present invention provides a method for preparing a bone resorption detection material, which comprises the method as shown in any one of the following (1)-(3):

[0016] (1) contacting the inner wall of an eggshell from which egg liquid and egg membrane have been removed with a treating agent;

[0017] (2) polishing the inner wall of the eggshell from which the egg liquid and egg membrane have been removed;

[0018] (3) The inner wall of the eggshell from which the egg liquid and egg membrane have been removed is subjected to ultrasonic treatment.

[0019] The present invention has the following beneficial effects:

[0020] The present invention provides a kit for bone absorption detection, which can not only observe the bone absorption function and quantify (parameters such as the number, size and depth of absorption pits), but also observe the morphology, quantity and size of cells in the state of bone absorption, providing a more realistic research state of bone absorption cells. However, the existing bone absorption detection products have poor light transmittance of bone slices, and the morphology of cells cannot be observed. The hydroxyapatite material coated with the orifice plate is too thin and is easily absorbed by osteoclasts, resulting in material damage, and the cell state of the absorbing material cannot be observed.

[0021] The cells on the eggshell are closer to the state of cells in the body. When the eggshell thickness reaches 0.1mm, immunohistochemistry and chemical dye staining can still be performed, making the study of bone absorption mechanism more realistic.

[0022] The kit provided by the present invention can realize multi-dimensional observation of absorption pits (three-dimensional or more dimensional analysis), while the orifice plate material coated with hydroxyapatite material is too thin to only see the absorption area but not the thickness, and the thickness difference of potential absorption pits is easily ignored.

[0023] In addition, the kit provided by the present invention has good application prospects in osteoclast bone resorption detection or screening of bone resorption drugs. BRIEF DESCRIPTION OF THE DRAWINGS

[0024] In order to more clearly illustrate the technical solutions of the embodiments of the present invention, the drawings required for use in the embodiments are briefly introduced below. It should be understood that the following drawings only show certain embodiments of the present invention and therefore should not be regarded as limiting the scope. For ordinary technicians in this field, other related drawings can be obtained based on these drawings without creative work.

[0025] Figure 1 The scanning electron micrographs of bone absorption of the porous plate coated with hydroxyapatite (left) and the scanning electron micrographs of bone absorption of the eggshell in the porous plate of Example 1 (right);

[0026] Figure 2 The figure is the Trap staining result of Example 2 (left) and the immunofluorescence micrograph of Example 3 (right). DETAILED DESCRIPTION

[0027] References to embodiments of the present invention will now be provided in detail, one or more examples of which are described below. Each example is provided as an explanation rather than a limitation of the present invention. In fact, it will be apparent to those skilled in the art that various modifications and variations may be made to the present invention without departing from the scope or spirit of the present invention. For example, a feature illustrated or described as part of one embodiment may be used in another embodiment to produce a further embodiment.

[0028] In a first aspect, the present invention provides a kit for bone absorption detection, comprising: a multi-well plate and a bone absorption detection material prepared from eggshells.

[0029] Eggshells include but are not limited to poultry eggshells such as chicken eggshells, duck eggshells, goose eggshells, and bird eggshells; birds such as turkeys, quails, pheasants, ostriches, egrets, sparrows, pigeons, or swallows.

[0030] As used herein, the term "egg" refers to an avian egg of a bird containing a viable or living embryo. In one embodiment, the term "egg" is intended to refer to a fertilized avian egg. In one embodiment, the egg is an egg containing an avian embryo capable of undergoing normal embryogenesis.

[0031] In one embodiment, the multi-well plate comprises: a frame, a culture strip composed of a plurality of culture wells arranged in series, the culture strip being mounted on the frame; the number of the culture strips is an odd number or an even number, and the number of the plurality of cell culture wells on each culture strip is an odd number or an even number. The culture strip can be detached from the frame.

[0032] In another embodiment, the multi-well plate includes: a substrate and cell culture wells distributed in an array on the substrate, and the substrate and the culture wells are integrally formed.

[0033] The cross-sectional shape of the cell culture hole includes but is not limited to: circle, square, rhombus, ellipse, trapezoid, hexagon, heptagon, octagon or polygon, and the number of sides of the polygon is greater than 8.

[0034] In a preferred embodiment of the present invention, the multi-well plate is provided with a plurality of cell culture wells, and the bone absorption detection materials are arranged in the cell culture wells.

[0035] In a preferred embodiment of the present invention, the number of cell culture wells on the multi-well plate is 16, 24, 25, 36, 72, 96 or 128.

[0036] In a preferred embodiment of the present invention, the kit further comprises: immunohistochemical reagents and / or active dyes.

[0037] When only the bone cell absorption pits are observed, the kit may not include immunohistochemical reagents and / or active dyes. When the bone cell absorption pits are observed, the eggshell is first cleaned with a cell remover and then observed after drying. In other embodiments, in order to more clearly observe the morphology of the absorption pits, the eggshell after the cells are removed can be stained with an active dye and then observed.

[0038] In order to observe cells, especially living cells, those skilled in the art may treat the eggshell with immunohistochemical reagents and / or stain with active dyes.

[0039] In a preferred embodiment of the present invention, the immunohistochemical reagent includes at least one of the following substances: an antibody or an antigen-binding fragment thereof and an antibody conjugate; the antibody conjugate includes: an antibody labeled with a detectable marker or an antigen-binding fragment labeled with a detectable marker.

[0040] Immunohistochemical reagents include but are not limited to immunofluorescence, immunoenzyme, immunoferritin, immunogold and radioimmunoautography reagents.

[0041] In a preferred embodiment of the present invention, an antibody conjugate refers to an antibody or an antigen-binding fragment thereof labeled with a detectable marker. The antibody conjugate may also be referred to as an "immunoconjugate". A person skilled in the art will understand that a "conjugate" refers to a new molecular entity formed by two or more molecules connected to each other by covalent bonds. The antibody and the payload may be coupled by a cleavable linker such as a peptide group or a disulfide bond.

[0042] The term "antigen binding fragment" refers to all proteins / protein fragments containing CDR regions, especially antibodies or antibody functional fragments. "Antigen binding fragments" include antigen compound binding fragments of the above-mentioned antibodies, including Fab, F(ab')2, Fd, Fv, scFv, bispecific antibodies, multispecific antibodies and antibody minimum recognition units, as well as single-chain derivatives of these antibodies and fragments. The type of antibody can be selected from IgG1, IgG2, IgG3, IgG4, IgA, IgM, IgE, IgD, etc. In addition, the term "antibody" includes naturally occurring antibodies and non-naturally occurring antibodies, including, for example, chimeric, bifunctional and humanized antibodies, and related synthetic isoforms. The term "antibody" can be used interchangeably with "immunoglobulin".

[0043] Detectable markers refer to a class of substances that have properties that can be directly observed by the naked eye or detected or detected by instruments, such as luminescence, color development, radioactivity, etc., through which qualitative or quantitative detection of the corresponding target can be achieved.

[0044] In a preferred embodiment of the present invention, the detectable marker is selected from fluorescent dyes, enzymes that catalyze substrate color development, radioactive isotopes, chemiluminescent reagents, and nanoparticle markers. In actual use, those skilled in the art can select a suitable marker according to the detection conditions or actual needs. No matter what marker is used, it belongs to the protection scope of the present invention.

[0045] Fluorescent dyes include, but are not limited to, fluorescein dyes and their derivatives (for example, including but not limited to fluorescein isothiocyanate (FITC), hydroxyfluorescein (FAM), tetrachlorofluorescein (TET), etc. or their analogs), rhodamine dyes and their derivatives (for example, including but not limited to red rhodamine (RBITC), tetramethylrhodamine (TAMRA), rhodamine B (TRITC), etc. or their analogs), Cy series dyes and their derivatives (for example, including but not limited to Cy2, Cy3, Cy3B, Cy3.5, Cy5, Cy5 .5, Cy3, etc. or their analogs), Alexa series dyes and their derivatives (for example, including but not limited to AlexaFluor350, 405, 430, 488, 532, 546, 555, 568, 594, 610, 33, 647, 680, 700, 750, etc. or their analogs) and protein dyes and their derivatives (for example, including but not limited to phycoerythrin (PE), phycocyanin (PC), allophycocyanin (APC), prephycocyanin-chlorophyll protein (preCP), etc.).

[0046] In an alternative embodiment, the enzyme that catalyzes the color development of the substrate includes, but is not limited to, alkaline phosphatase, β-galactosidase, glucose oxidase, carbonic anhydrase, acetylcholinesterase, and 6-phosphoglucose deoxidase.

[0047] In an alternative embodiment, the radioactive isotopes include but are not limited to 212 Bi, 131 I. 111 In, 90 Y. 186 Re, 211 At 125 I. 188 Re, 153 Sm, 213 Bi, 32 P. 94 mTc, 99 mTc, 203 Pb, 67 Ga, 68 Ga, 43 Sc, 47 Sc, 110 mIn、 97 Such as 62 Cu, 64 Cu, 67 Cu, 68 Cu, 86 Y. 88 Y. 121 Sn, 161 Tb, 166 Ho, 105 Rh, 177 Lu, 172 Lu and 18 F.

[0048] In an optional embodiment, the chemiluminescent reagent includes, but is not limited to, luminol and its derivatives, lucigenin, crustacean fluorescein and its derivatives, bipyridine ruthenium and its derivatives, acridinium esters and their derivatives, dioxetanes and their derivatives, lophanes and their derivatives, and peroxyoxalates and their derivatives.

[0049] In an optional embodiment, the nanoparticle markers include but are not limited to nanoparticles and colloids; the nanoparticles include but are not limited to organic nanoparticles, magnetic nanoparticles, quantum dot nanoparticles and rare earth complex nanoparticles.

[0050] In alternative embodiments, colloids include, but are not limited to, colloidal metals, disperse dyes, dye-labeled microspheres, and latex.

[0051] In alternative embodiments, colloidal metals include, but are not limited to, colloidal gold, colloidal silver, and colloidal selenium.

[0052] Reactive dyes such as acid fuchsin, alcian blue, alizarin red S, aniline blue WS, auramine O, azo carmine B, azo carmine G, azure A, azure B, azure C, basic fuchsin, Bismarck brown Y, brilliant cresol blue, brilliant green, carmine, chlorazole black E, Congo red, CI cresol violet, crystal violet, Darrow red, eosin B, eosin Y, erythrosine, ethyl eosin, ethyl green, fast green FCF, fluorescein isothiocyanate, Giemsa stain, hematoxylin, hematoxylin & eosin, indigo carmine, Jana green B, Jenner stain 1899, light green SF, malachite green , Matthew Yellow, Methyl Orange, Methyl Violet 2B, Methylene Blue, Methylene Blue, Methylene Violet, (Methylene Blue), Neutral Red, Aniline Black, Nile Blue A, Nuclear Fast Red, Oil Red, Orange G, Orange II, Orcein Red, Pararosaniline, Root Bark Red B, Strong Protein Silver S, Pyronine B, Pyronine, Azure Blue, Rose Bengal, Safranin O, Sudan Black B, Sudan III, Sudan IV, Tetrachrome Stain (MacNeal), Thionine, Toluidine Blue, Weigert, Wright's Stain, Nitrate Yellow, Nile Red, Catechol Violet, Tetramethylbenzidine, and any combination thereof.

[0053] In a preferred embodiment of the present invention, the kit further comprises: a cell scavenger, the active ingredient of which is a weak alkaline reagent. In addition, when only the observation of cells is involved and the absorption pits are not detected, the kit may also not comprise a cell scavenger.

[0054] The cell clearer can effectively remove cells on the surface of absorption pits or bone absorption detection materials, thereby facilitating the detection and analysis of parameters such as the number, size, and depth of absorption pits.

[0055] In order to enhance the efficiency of cell removal, additional conditions such as ultrasound and vibration can be added while introducing the cell remover.

[0056] In a preferred embodiment of the present invention, the weak base agent is selected from an organic weak base solution, an inorganic weak base solution, or a mixture thereof. Since the eggshell contains components such as calcium carbonate, strong or weak acids cannot be used for treatment to prevent damage to the eggshell material, especially to prevent the acidic agent from corroding the inherent morphology of the absorption pit.

[0057] In a preferred embodiment of the present invention, the organic weak base includes but is not limited to at least one of the following: disodium hydrogen citrate, dipotassium hydrogen citrate, sodium citrate, potassium citrate, sodium acetate, potassium acetate, sodium propionate, potassium propionate, sodium butyrate, potassium butyrate, sodium tartrate, potassium tartrate, sodium benzoate, trimethylamine, ethylamine, diethylamine, triethylamine, propylamine, cyclopropylamine, dipropylamine, diisopropylamine, tripropylamine butylamine, cyclobutylamine, isobutylamine, sec-butylamine, tert-butylamine, dibutylamine, diisobutylamine, tributylamine, pentylamine, cyclopentylamine, isopentylamine, sec-pentylamine, dipentylamine, hexylamine, and cyclohexylamine; the inorganic weak base is selected from at least one of the following: sodium carbonate, ammonium carbonate, ammonium hydroxide, potassium carbonate, lithium carbonate, sodium bicarbonate, ammonium bicarbonate, potassium bicarbonate, lithium bicarbonate, disodium hydrogen phosphate, dipotassium hydrogen phosphate, trisodium phosphate, and sodium silicate.

[0058] In a preferred embodiment of the present invention, the pH of the weak base is less than 7.8 to 8.5.

[0059] In a preferred embodiment of the present invention, the bone absorption detection material is prepared by removing the membrane from the eggshell, and can be directly observed without thinning.

[0060] In other embodiments, thickness processing is performed after membrane removal, and the thickness of the bone absorption detection material is 0.1 mm to 0.5 mm.

[0061] In a second aspect, the present invention provides an application of a kit for detecting osteoclast bone resorption or screening bone resorption drugs, wherein the application includes any of the following application modes:

[0062] (1) contacting the microplate of the kit with osteoclasts to detect absorption pits;

[0063] (2) contacting the microplate of the kit with osteoclasts to obtain cell images;

[0064] (3) The microplate of the kit is placed in contact with osteoclasts, and after obtaining a cell image, absorption pits are detected.

[0065] In the above application mode (1), the eggshell is contacted with osteoclasts, and then cultured for 5-7 days; and the osteoclast bone resorption pits are detected. In a preferred embodiment of the present invention, the method for detecting osteoclast bone resorption is: bone resorption pit morphology analysis method.

[0066] When osteoclasts adhere to the surface of bone matrix, a local slightly acidic environment will be formed between the rest of the bone matrix, which will then exert the bone resorption function and form resorption pits, namely bone resorption pits. Bone resorption pits are the most direct result of osteoclast bone resorption, and their number, size, depth and area can directly reflect the ability of osteoclasts to resorb bones. The bone resorption pit morphology analysis method is to evaluate the bone resorption function of osteoclasts by performing computer morphometric analysis of bone resorption pits.

[0067] The above application method (2) includes: fixing the bone absorption detection material in the microplate, then treating it with an immunohistochemical reagent or a reactive dye, and then observing the cells.

[0068] The above-mentioned application method (3) includes: using immunohistochemical reagents or active dyes to stain eggshells from which cells have been removed, or using immunohistochemical reagents or active dyes to treat eggshells containing cells, obtaining cell images, and then performing bone resorption pit morphology detection (optical or scanning electron microscopy observation).

[0069] The kit provided by the present invention can be used to screen bone resorption drugs. According to the size and depth of the bone resorption pits, it is evaluated whether the test drug has the activity of inhibiting bone resorption cells and whether it has the effect of reducing bone resorption. The test drugs are sorted according to the test results, so as to screen and obtain the target bone resorption drug.

[0070] In a third aspect, the present invention provides a method for preparing a bone resorption detection material, which comprises the method as shown in any one of the following (1)-(3):

[0071] (1) contacting the inner wall of an eggshell from which egg liquid and egg membrane have been removed with a treating agent;

[0072] (2) polishing the inner wall of the eggshell from which the egg liquid and egg membrane have been removed;

[0073] (3) The inner wall of the eggshell from which the egg liquid and egg membrane have been removed is subjected to ultrasonic treatment.

[0074] After the membrane on the inner side of the eggshell is removed, it is more conducive to bone absorption and adhesion of osteoclasts. In an optional embodiment, the membrane may not be removed, and the osteoclasts may be contacted with the outer side of the eggshell for bone absorption detection.

[0075] The inside of the eggshell and / or the outside of the eggshell are in contact with osteoclasts; the contact includes but is not limited to cell inoculation, cell transplantation, etc.

[0076] Polishing and acid treatment are used to thin the eggshell. Too thick an eggshell will affect light transmittance, making it impossible to observe cells or stained proteins under a high-power microscope.

[0077] In a preferred embodiment of the present invention, the method further comprises: calculating the amount of the treatment agent to be added according to the thickness of the eggshell to be thinned;

[0078] The treating agent is selected from acids, sodium hydroxide and non-acid strong oxidants.

[0079] In a preferred embodiment of the present invention, the treating agent is selected from acid, sodium hydroxide and non-acid strong oxidizing agent;

[0080] In a preferred embodiment of the present invention, the acid is an organic acid and / or an inorganic acid;

[0081] In a preferred embodiment of the present invention, the inorganic acid is selected from hydrochloric acid, nitric acid, sulfuric acid, phosphoric acid, hydrofluoric acid and hypochlorous acid, and the organic acid is selected from acetic acid, propionic acid, butyric acid, succinic acid, citric acid, lactic acid, malic acid, tartaric acid, malonic acid, maleic acid, glutaric acid and aconitic acid;

[0082] In a preferred embodiment of the present invention, the non-acidic strong oxidant is selected from at least one of perchlorate, persulfate, dichromate and hydrogen peroxide;

[0083] In a preferred embodiment of the present invention, the non-acid strong oxidant is selected from at least one of potassium perchlorate, potassium permanganate, sodium hypochlorite, potassium hypochlorite, calcium hypochlorite, sodium perchlorate, calcium perchlorate, sodium persulfate, potassium persulfate, potassium dichromate, manganese dioxide and hydrogen peroxide.

[0084] In a preferred embodiment of the present invention, after the eggshells are treated according to any one of the methods (1) to (3), the method further includes cutting the treated eggshells. The cut eggshells can be directly placed on a multi-well plate for cell inoculation.

[0085] In order to make the purpose, technical scheme and advantages of the embodiments of the present invention clearer, the technical scheme in the embodiments of the present invention will be described clearly and completely below. If the specific conditions are not specified in the embodiments, they are carried out according to conventional conditions or conditions recommended by the manufacturer. If the manufacturer of the reagents or instruments used is not specified, they are all conventional products that can be purchased commercially.

[0086] The features and performance of the present invention are further described in detail below in conjunction with the embodiments.

[0087] Example 1

[0088] This embodiment provides a kit for absorption pit detection, including: a multi-well plate (24-well plate), a cell cleaning agent (0.25 mol / L ammonium hydroxide solution), and a bone absorption detection material prepared from eggshells is laid at the bottom of each cell culture well of the multi-well plate. In this embodiment, the thickness of the bone absorption detection material is 0.1 mm.

[0089] The preparation method of bone resorption detection material is as follows:

[0090] (1) Select eggs of uniform size, uniform color and smooth surface. Wash them thoroughly without leaving any marks on the surface. Wipe dry and set aside.

[0091] (2) Open the egg from the air chamber and pour out all the egg membrane and egg liquid inside, leaving at least 3 / 4 of the egg shell intact. Add water to mark the water level and record the water volume. Rinse it clean and wipe off excess water for later processing. Measure the thickness of the removed egg shell and record it.

[0092] (3) Weigh the complete 3 / 4 eggshell and add acid (30% hydrochloric acid) from the inside of the eggshell for digestion as needed. Calculate the amount of acid required according to the required thickness: for example, if the eggshell is 0.35 mm thick and weighs 8 g, and needs to be digested to a thickness of 0.1 mm, the weight required to digest 0.25 mm is 5.714 g.

[0093] The main component of eggshell is CaCO3, with a molecular weight of 100.09. Calculate the number of moles of CaCO3 that needs to be consumed: 5.714 / 100.09 = 0.057 mol;

[0094] According to the chemical reaction equation, taking hydrochloric acid as an example, CaCO3+2HCl=CaCl2+H2O+CO2 requires 0.057*2=0.114mol of hydrochloric acid. The calculated hydrochloric acid is completely diluted into water with a volume of 3 / 4 of the eggshell, and then poured into the eggshell for digestion. During the digestion process, pour out the acid to test the weight of the eggshell. When the digestion weight is close to 0.57g, stop the reaction and measure whether the eggshell thickness meets the requirements, 0.1mm±0.02mm.

[0095] (4) Clean the eggshells after thickness treatment and cut them in the middle of the abdomen according to the size of different orifice plates. The diameter of the eggshell in the middle is larger, which is more convenient for focusing and has a larger field of view. The diameter of the eggshell at the tail is too small to be convenient for observation and statistics.

[0096] Since the eggshells after thickness treatment are easy to break, they are placed in multi-well plates of different specifications after high temperature sterilization (the outside of the eggshell is placed upwards) to facilitate the subsequent cell culture staining lamp operation. Affix sealing film and cut each well into squares to facilitate multiple selections of wells. Cover the multi-well plate with a lid, put it in a separate well plate box and then package it.

[0097] The absorption pit observation method is as follows:

[0098] (1) Take out the cell culture multi-well plate from the kit, and seed an appropriate number of cells on the material according to the conventional culture requirements, and culture them as required by the experiment. Taking the induction of osteoclasts in a mouse monocyte 96-well plate as an example, separate the monocytes (osteoclast precursor cells) from the mouse bone marrow, treat them with α-MEM medium containing 50ng / ml M-CSF for 3 days, and then seed the plate. Seed 10,000 to 20,000 monocytes per well, and induce them with α-MEM medium containing 50ng / ml M-CSF+RANKL for 4 days, and change the medium every 2 days.

[0099] (2) After the culture is completed, the eggshell material is removed from the multi-well plate and washed with PBS;

[0100] (3) Place in ammonium hydroxide solution and sonicate for 5 min, repeat 3 times, and then wash with PBS;

[0101] (4) vacuum drying or natural drying using a gradient of 50% ethanol-70% ethanol-80% ethanol-90% ethanol-anhydrous ethanol;

[0102] (5) Send for scanning electron microscopy.

[0103] Results reference Figure 1 Middle right image. The absorption pit is observed in a more multi-dimensional manner, showing a 3D shape.

[0104] Example 2

[0105] This embodiment provides a kit for absorption pit detection, which is different from that of embodiment 1 in that it also includes 0.1% Alcian blue solution (g / v).

[0106] The difference between the absorption pit observation method and Example 1 is that after step (3) is completed, 0.1% Alcian blue solution (g / v) is directly added for 5 minutes, washed and dried, and observed under an optical microscope.

[0107] Example 3

[0108] This embodiment provides a kit for bone cell observation, which includes: a multi-well plate (24-well plate) and a Trap staining reagent.

[0109] The bottom of each cell culture well of the multi-well plate is paved with a bone absorption detection material made of eggshells. In this embodiment, the thickness of the bone absorption detection material is 0.1 mm.

[0110] The preparation method of bone absorption detection material is the same as that in Example 1.

[0111] The cell observation method is as follows:

[0112] (1) Take out the cell culture multiwell plate from the kit, and seed a suitable number of cells on the material according to the method of step (1) of the absorption pit observation method in Example 1, and culture them conventionally for the time required by the experiment.

[0113] (2) After the culture is completed, the eggshell material is removed from the multi-well plate and washed with PBS;

[0114] (3) Add 4% paraformaldehyde (or 10% formaldehyde) as a fixative to cover the material, fix for 10 minutes, and perform staining according to the instructions of the tartrate-resistant acid phosphatase (Trap) staining kit (Sigma Aldrich; 387A-1KT). The maximum magnification for eggshells with a thickness of 0.4 mm is 100 times (eyepiece 10X, objective lens 10X); the maximum magnification for eggshells with a thickness of 0.2 mm is 200 times; and the maximum magnification for eggshells with a thickness of 0.1 mm is 400 times.

[0115] Trap staining results refer to Figure 2 As shown in the left picture, Trap staining can be performed directly on the material to observe the morphology, quantity and size of cells, which cannot be achieved by other similar products; and the cells on the eggshell are closer to the state of cells in the body.

[0116] Example 4

[0117] Compared with Example 3, the only difference is that after fixation for 10 min in step (3), immunofluorescence staining was performed with FITC-labeled pen cyclic peptide fluorescent dye (sigma, P5252-1MG), DAPI mounting medium (sigma, F6057-20ML) was used to seal the slices, and imaging was performed with a fluorescence confocal microscope (Olympus FV1200). The immunofluorescence imaging results were referred to Figure 2 As shown in the right picture, the skeleton of the fluorescent cells can be clearly seen under a 200x microscope.

[0118] Example 5

[0119] Compared with Example 3, the only difference is that after fixation for 10 minutes in step (3), the excess antibody is washed off after reaction with the primary antibody for immunohistochemistry, and then incubated with the fluorescent secondary antibody for immunohistochemical staining. After washing, the nucleus is stained with DAPI and the slide is sealed for observation under a fluorescent confocal microscope.

[0120] Example 6

[0121] This embodiment provides a kit for absorption pit detection and cell observation, including: a multi-well plate (24-well plate), a cell cleaning agent (0.25 mol / L ammonium hydroxide solution), a Trap staining reagent, and a 0.1% Alcian blue solution (g / v). A bone absorption detection material prepared from eggshells is laid at the bottom of each cell culture well of the multi-well plate. The thickness of the bone absorption detection material in this embodiment is 0.2 mm.

[0122] The preparation method of the bone absorption detection material is the same as that of Example 1, except that 0.228 mol of hydrochloric acid is used for digestion.

[0123] The cell observation method is the same as in Example 3, and then the cells are removed with a cell cleaning agent, in the same manner as steps (3) to (5) in the absorption pit observation method of Example 1.

[0124] In other embodiments, cells may be removed with a cell cleaning agent, stained with Alcian blue for 3-5 minutes, washed with PBS three times, and observed under an optical microscope.

[0125] Example 6

[0126] The difference between this embodiment and embodiment 1 is that step (3) in the preparation method of bone absorption detection material is different. In this embodiment, the bone absorption detection material is prepared by grinding. Eggshells of the required size and shape are taken, and the inner thickness of the eggshells is ground with sandpaper or a mechanical grinding disc at a low speed (45-75 rpm), and the thickness is measured with a micrometer until the required thickness requirement is reached.

[0127] Comparative Example 1

[0128] A commercially available 48-well plate (coated with calcium phosphate-bound fluorescein-labeled chondroitin sulfate, CSR-BRA-48P, cosmobio, Whatman) was used as a control, and the same cells as in Example 1 were inoculated according to the method of the kit, cultured for 5 days, and observed directly under a microscope ( Figure 1 left side).

[0129] The results showed that the coating material was too thin to see the absorption area, not the thickness, and potential differences were easily overlooked.

[0130] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. For those skilled in the art, the present invention may have various modifications and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included in the protection scope of the present invention.

Claims

1. A kit for detecting bone resorption, characterized in that: It includes: Multi-well plates, bone resorption detection materials prepared from eggshells.

2. The kit according to claim 1, characterized in that The multi-porous plate is provided with a plurality of cell culture wells, and the bone absorption detection material is arranged in the cell culture wells.

3. The kit according to claim 1, characterized in that The kit further comprises: immunohistochemical reagents and / or active dyes; Preferably, the immunohistochemical reagent comprises at least one of the following substances: an antibody or an antigen-binding fragment thereof, and an antibody conjugate; the antibody conjugate comprises: an antibody labeled with a detectable marker; Preferably, the detectable marker is selected from fluorescent dyes, enzymes that catalyze substrate color development, radioactive isotopes, chemiluminescent agents and nanoparticle markers.

4. The kit according to claim 1, characterized in that The kit also includes: a cell clearing agent, wherein the active ingredient of the cell clearing agent is a weak alkaline reagent; Preferably, the weak base reagent is selected from an organic weak base solution, an inorganic weak base solution, or a mixture thereof; Preferably, the organic weak base is selected from at least one of the following: disodium hydrogen citrate, dipotassium hydrogen citrate, sodium citrate, potassium citrate, sodium acetate, potassium acetate, sodium propionate, potassium propionate, sodium butyrate, potassium butyrate, sodium tartrate, potassium tartrate, sodium benzoate, trimethylamine, ethylamine, diethylamine, triethylamine, propylamine, cyclopropylamine, dipropylamine, diisopropylamine, tripropylaminebutylamine, cyclobutylamine, isobutylamine, sec-butylamine, tert-butylamine, dibutylamine, diisobutylamine, tributylamine, pentylamine, cyclopentylamine, isopentylamine, sec-pentylamine, dipentylamine, hexylamine, cyclohexylamine; the inorganic weak base is selected from at least one of the following: sodium carbonate, ammonium carbonate, ammonium hydroxide, potassium carbonate, lithium carbonate, sodium bicarbonate, ammonium bicarbonate, potassium bicarbonate, lithium bicarbonate, disodium hydrogen phosphate, dipotassium hydrogen phosphate, trisodium phosphate and sodium silicate.

5. The kit according to claim 4, characterized in that The pH of the weak base is less than 7.8-8.

5.

6. The kit according to claim 1, characterized in that The bone absorption detection material is prepared by removing the membrane from eggshells; Preferably, it is made from eggshells after membrane removal and thickness treatment; Preferably, the thickness of the bone absorption detection material is 0.1 mm to 0.5 mm.

7. Use of the kit according to any one of claims 1 to 6 in detecting osteoclast bone resorption or screening bone resorption drugs, characterized in that: The application includes any of the following application modes: (1) contacting the microplate of the kit with osteoclasts to detect absorption pits; (2) contacting the microplate of the kit with osteoclasts to obtain a cell image; (3) The microplate of the kit is contacted with osteoclasts, and the absorption pits are detected after obtaining cell images.

8. A method for preparing a bone absorption detection material, characterized in that: It includes the method shown in any one of the following (1)-(3): (1) contacting the inner wall of the eggshell from which the egg liquid and the egg membrane have been removed with a treatment agent that can react with calcium carbonate; (2) polishing the inner wall of the eggshell from which the egg liquid and egg membrane have been removed; (3) The inner wall of the eggshell from which the egg liquid and egg membrane have been removed is subjected to ultrasonic treatment.

9. The method for preparing the bone absorption detection material according to claim 8, characterized in that: The method further comprises: calculating the amount of treatment agent to be added according to the thickness of the eggshell to be thinned; Preferably, the treating agent is selected from acids, sodium hydroxide and non-acid strong oxidants; Preferably, the acid is an organic acid and / or an inorganic acid; Preferably, the inorganic acid is selected from hydrochloric acid, nitric acid, sulfuric acid, phosphoric acid, hydrofluoric acid and hypochlorous acid, and the organic acid is selected from acetic acid, propionic acid, butyric acid, succinic acid, citric acid, lactic acid, malic acid, tartaric acid, malonic acid, maleic acid, glutaric acid and aconitic acid; Preferably, the non-acid strong oxidant is selected from at least one of perchlorate, persulfate, dichromate and hydrogen peroxide; Preferably, the non-acid strong oxidant is selected from at least one of potassium perchlorate, potassium permanganate, sodium hypochlorite, potassium hypochlorite, calcium hypochlorite, sodium perchlorate, calcium perchlorate, sodium persulfate, potassium persulfate, potassium dichromate, manganese dioxide and hydrogen peroxide.

10. The method for preparing the bone absorption detection material according to claim 8, characterized in that: After the eggshells are processed according to any one of the methods (1) to (3), the method further includes cutting the processed eggshells.